Quick Answer
ANAVEX LIFE SCIENCES CORP. reported R&D Expense of $37.59 million for fiscal year 2025.
ANAVEX LIFE SCIENCES CORP. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $37.59M | -10.1% |
| 2024 | $41.84M | -4.3% |
| 2023 | $43.72M | +15.3% |
| 2022 | $37.92M | +15.0% |
| 2021 | $32.98M | +30.7% |
| 2020 | $25.23M | +13.3% |
| 2019 | $22.26M | +66.8% |
| 2018 | $13.34M | +25.0% |
| 2017 | $10.67M | +47.1% |
| 2016 | $7.25M | +219.3% |
| 2015 | $2.27M | +210.2% |
| 2014 | $732.4K | +177.6% |
| 2013 | $263.8K | -90.1% |
| 2012 | $2.65M | +2.2% |
| 2011 | $2.60M | -4.8% |
| 2010 | $2.73M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $4.66M | -55.4% | -53.2% |
| June 30, 2025 | $9.96M | -15.7% | +0.7% |
| March 31, 2025 | $9.89M | +1.7% | -5.3% |
| December 31, 2024 | $10.45M | +20.3% | -11.6% |
| June 30, 2024 | $11.81M | +14.9% | +21.4% |
| March 31, 2024 | $9.73M | -14.0% | +12.0% |
| December 31, 2023 | $8.68M | -28.0% | -15.5% |
| June 30, 2023 | $10.28M | +10.9% | -9.1% |
- ANAVEX LIFE SCIENCES CORP. showed a decrease of -10.1% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2025 period, ANAVEX LIFE SCIENCES CORP.’s r&d expense has grown by 1277.6% (from $2.73 million to $37.59 million).
- The most recent figure is from ANAVEX LIFE SCIENCES CORP.’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: